<DOC>
	<DOCNO>NCT02658747</DOCNO>
	<brief_summary>This multi-center retrospective observational research study collect data participant initiate docetaxel treatment relapse non-small cell lung cancer ( NSCLC ) 6 year start data collection completed/stopped docetaxel treatment least 30 day prior data collection . The primary goal study describe percentage participant least one neutropenic sepsis ( NS ) episode follow initiation treatment single-agent docetaxel . Data collect end docetaxel treatment plus additional 30 day allow presentation toxicity .</brief_summary>
	<brief_title>Neutropenic Sepsis Patients With Non-Small Cell Lung Cancer Treated With Single-Agent Docetaxel Associated Resource Use UK</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<criteria>Diagnosed locally advanced metastatic ( stage Ill IV ) nonsmall cell lung cancer ( NSCLC ) Relapsed disease following , unable tolerate , least one line prior chemotherapy Initiated singleagent docetaxel maximum 6 year prior date collection Aged 18 year date first docetaxel dose Completed stop treatment docetaxel least 30 day prior date data collection Receiving docetaxel interventional clinical trial For detail absolute neutrophil count record</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>